Handelsbanken Fonder’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.4M | Buy |
80,866
+8,200
| +11% | +$399K | 0.01% | 529 |
|
|
2026
Q1 | $3.12M | Hold |
72,666
| – | – | 0.01% | 595 |
|
|
2025
Q4 | $3.19M | Sell |
72,666
-7,200
| -9% | -$298K | 0.01% | 595 |
|
|
2025
Q3 | $3.3M | Buy |
79,866
+13,900
| +21% | +$559K | 0.01% | 574 |
|
|
2025
Q2 | $2.91M | Sell |
65,966
-6,100
| -8% | -$244K | 0.01% | 537 |
|
|
2025
Q1 | $2.66M | Hold |
72,066
| – | – | 0.01% | 558 |
|
|
2024
Q4 | $2.4M | Sell |
72,066
-6,400
| -8% | -$208K | 0.01% | 601 |
|
|
2024
Q3 | $2.04M | Buy |
78,466
+17,200
| +28% | +$427K | 0.01% | 659 |
|
|
2024
Q2 | $1.38M | Sell |
61,266
-3,100
| -5% | -$68.8K | 0.01% | 705 |
|
|
2024
Q1 | $1.53M | Hold |
64,366
| – | – | 0.01% | 683 |
|
|
2023
Q4 | $1.54M | Buy |
64,366
+9,200
| +17% | +$200K | 0.01% | 628 |
|
|
2023
Q3 | $1.21M | Hold |
55,166
| – | – | 0.01% | 665 |
|
|
2023
Q2 | $1.05M | Buy |
55,166
+10,600
| +24% | +$204K | 0.01% | 727 |
|
|
2023
Q1 | $865K | Hold |
44,566
| – | – | 0.01% | 745 |
|
|
2022
Q4 | $715K | Hold |
44,566
| – | – | ﹤0.01% | 776 |
|
|
2022
Q3 | $699K | Sell |
44,566
-2,900
| -6% | -$56K | ﹤0.01% | 785 |
|
|
2022
Q2 | $988K | Hold |
47,466
| – | – | 0.01% | 689 |
|
|
2022
Q1 | $1.08M | Sell |
47,466
-13,500
| -22% | -$264K | 0.01% | 768 |
|
|
2021
Q4 | $1.11M | Hold |
60,966
| – | – | 0.01% | 837 |
|
|
2021
Q3 | $1.29M | Buy |
60,966
+4,400
| +8% | +$81.7K | 0.01% | 776 |
|
|
2021
Q2 | $1.03M | Buy |
56,566
+4,400
| +8% | +$103K | 0.01% | 903 |
|
|
2021
Q1 | $1.18M | Hold |
52,166
| – | – | 0.01% | 770 |
|
|
2020
Q4 | $1.05M | Hold |
52,166
| – | – | 0.01% | 811 |
|
|
2020
Q3 | $1.27M | Hold |
52,166
| – | – | 0.01% | 655 |
|
|
2020
Q2 | $1.24M | Buy |
+52,166
| New | +$1.21M | 0.01% | 627 |
|
|
2018
Q4 | – | Sell |
-89,000
| Closed | -$1.58M | – | 177 |
|
|
2018
Q3 | $1.58M | Sell |
89,000
-239,000
| -73% | -$4.66M | 0.03% | 166 |
|
|
2018
Q2 | $7.06M | Buy |
328,000
+19,000
| +6% | +$393K | 0.14% | 137 |
|
|
2018
Q1 | $6.84M | Buy |
309,000
+38,000
| +14% | +$1.05M | 0.13% | 135 |
|
|
2017
Q4 | $8.24M | Sell |
271,000
-58,000
| -18% | -$1.54M | 0.18% | 107 |
|
|
2017
Q3 | $7.97M | Sell |
329,000
-20,000
| -6% | -$532K | 0.18% | 110 |
|
|
2017
Q2 | $8.6M | Hold |
349,000
| – | – | 0.22% | 104 |
|
|
2017
Q1 | $7.56M | Sell |
349,000
-101,000
| -22% | -$2.05M | 0.21% | 97 |
|
|
2016
Q4 | $6.71M | Buy |
450,000
+85,000
| +23% | +$1.23M | 0.21% | 104 |
|
|
2016
Q3 | $4.67M | Buy |
365,000
+295,000
| +421% | +$3.19M | 0.14% | 124 |
|
|
2016
Q2 | $547K | Buy |
+70,000
| New | +$403K | 0.02% | 151 |
|
Other funds holding EXEL
AT
DCM
AB
PFSRSONJ
Handelsbanken Fonder's EXEL Position: Q2 2026 in Review
Handelsbanken Fonder increased its Exelixis (EXEL) stake by 11% in Q2 2026, buying an estimated $399K and bringing the position to 80,866 shares worth $4.4M. The position accounts for 0.01% of the portfolio, ranked #529.
Handelsbanken Fonder first reported a position in EXEL in Q2 2016 and has held it in 35 quarters since. The position peaked at $8.6M in Q2 2017. 200 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Handelsbanken Fonder held 80,866 shares of Exelixis worth $4.4M as of Q2 2026.
- Handelsbanken Fonder bought 8,200 Exelixis shares in Q2 2026, an estimated $399K.
- Exelixis made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #529 holding.
- Handelsbanken Fonder first reported a position in Exelixis in Q2 2016 and has held it in 35 quarters since.
- Handelsbanken Fonder's Exelixis position peaked at $8.6M in Q2 2017.
- 200 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.